Layer P, Gröger G
Department of Medicine, University of Essen, FRG.
Digestion. 1993;54 Suppl 2:10-4. doi: 10.1159/000201097.
The activities of pancreatic enzymes decrease during their passage from the duodenum to the terminal ileum, but degradation rates of individual enzymes are different. Whereas lipase activity is lost most rapidly, proteases and amylase are more stable. The mechanism by which lipase activity is destroyed is proteolysis, mainly by the action of chymotrypsin. This mechanism is also operative in patients with chronic exocrine pancreatic insufficiency. It explains why fat malabsorption develops earlier compared with protein or starch malabsorption. The substitution of lipase is also more difficult than that of other enzymes, because it is more rapidly destroyed by proteases. Conversely, inactivation of proteases improves intraluminal activity of lipase not only in healthy individuals but also in patients with chronic pancreatitis. Other factors that contribute to problems in lipase substitution therapy include acid-peptic destruction of unprotected enzyme preparations and unphysiological particle sizes of enteric-coated capsules or pellets. Recent data suggest that the adaptation of the diameter of enteric-coated pancreatin micropellets into the range that permits gastric emptying in synchronicity with the meal improves their digestive efficacy.
胰腺酶从十二指肠到回肠末端的过程中活性降低,但各酶的降解速率不同。脂肪酶活性丧失最快,而蛋白酶和淀粉酶则更稳定。脂肪酶活性被破坏的机制是蛋白水解,主要是由胰凝乳蛋白酶的作用引起的。这种机制在慢性外分泌性胰腺功能不全患者中也起作用。这就解释了为什么脂肪吸收不良比蛋白质或淀粉吸收不良更早出现。脂肪酶的替代也比其他酶更困难,因为它更容易被蛋白酶破坏。相反,蛋白酶的失活不仅能提高健康个体,也能提高慢性胰腺炎患者肠腔内脂肪酶的活性。脂肪酶替代疗法中出现问题的其他因素包括未受保护的酶制剂被胃酸消化破坏,以及肠溶胶囊或微丸的颗粒大小不符合生理要求。最近的数据表明,将肠溶胰酶微丸的直径调整到允许与进餐同步胃排空的范围内,可提高其消化功效。